Literature DB >> 33091379

Edge Strand Dissociation and Conformational Changes in Transthyretin under Amyloidogenic Conditions.

Matthew C Childers1, Valerie Daggett2.   

Abstract

During amyloidogenesis, proteins undergo conformational changes that allow them to aggregate and assemble into insoluble, fibrillar structures. Soluble oligomers that form during this process typically contain 2-24 monomeric subunits and are cytotoxic. Before the formation of these soluble oligomers, monomeric species first adopt aggregation-competent conformations. Knowledge of the structures of these intermediate states is invaluable to the development of molecular strategies to arrest pathological amyloid aggregation. However, the highly dynamic and interconverting nature of amyloidogenic species limits biophysical characterization of their structures during amyloidogenesis. Here, we use molecular dynamics simulations to probe conformations sampled by monomeric transthyretin under amyloidogenic conditions. We show that certain β-strands in transthyretin tend to unfold and sample nonnative conformations and that the edge strands in one β-sheet (the DAGH sheet) are particularly susceptible to conformational changes in the monomeric state. We also find that changes in the tertiary structure of transthyretin can be associated with disruptions to the secondary structure. We evaluated the conformations produced by molecular dynamics by calculating how well molecular-dynamics-derived structures reproduced NMR-derived interatomic distances. Finally, we leverage our computational results to produce experimentally testable hypotheses that may aid experimental explorations of pathological conformations of transthyretin.
Copyright © 2020 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33091379      PMCID: PMC7732750          DOI: 10.1016/j.bpj.2020.08.043

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  65 in total

1.  Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease.

Authors:  Roger S Armen; Mari L DeMarco; Darwin O V Alonso; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

3.  Molecular dynamics simulation of amyloid beta dimer formation.

Authors:  B Urbanc; L Cruz; F Ding; D Sammond; S Khare; S V Buldyrev; H E Stanley; N V Dokholyan
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

4.  Molecular dynamics simulation of the unfolding of barnase: characterization of the major intermediate.

Authors:  A Li; V Daggett
Journal:  J Mol Biol       Date:  1998-01-30       Impact factor: 5.469

Review 5.  Inhibition of protein aggregation and amyloid formation by small molecules.

Authors:  Andrew J Doig; Philippe Derreumaux
Journal:  Curr Opin Struct Biol       Date:  2015-01-02       Impact factor: 6.809

Review 6.  The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases.

Authors:  Nunilo Cremades; Christopher M Dobson
Journal:  Neurobiol Dis       Date:  2017-07-12       Impact factor: 5.996

7.  Identification of a common binding mode for imaging agents to amyloid fibrils from molecular dynamics simulations.

Authors:  Katrine Kirkeby Skeby; Jesper Sørensen; Birgit Schiøtt
Journal:  J Am Chem Soc       Date:  2013-08-19       Impact factor: 15.419

Review 8.  Agitation of amyloid proteins to speed aggregation measured by ThT fluorescence: a call for standardization.

Authors:  Kiersten M Batzli; Brian J Love
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2014-09-16       Impact factor: 7.328

9.  Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity.

Authors:  S L McCutchen; W Colon; J W Kelly
Journal:  Biochemistry       Date:  1993-11-16       Impact factor: 3.162

10.  The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

Authors:  Z Lai; W Colón; J W Kelly
Journal:  Biochemistry       Date:  1996-05-21       Impact factor: 3.162

View more
  4 in total

Review 1.  Update on Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.

Authors:  Caleb J Hood; Nicholas S Hendren; Rose Pedretti; Lori R Roth; Lorena Saelices; Justin L Grodin
Journal:  Curr Heart Fail Rep       Date:  2022-08-05

Review 2.  Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism.

Authors:  Jin-Beom Si; Bokyung Kim; Jin Hae Kim
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

3.  Divergence Entropy-Based Evaluation of Hydrophobic Core in Aggressive and Resistant Forms of Transthyretin.

Authors:  Mateusz Banach; Katarzyna Stapor; Piotr Fabian; Leszek Konieczny; Irena Roterman
Journal:  Entropy (Basel)       Date:  2021-04-13       Impact factor: 2.524

4.  Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis.

Authors:  Bokyung Kim; Young Ho Ko; Massimiliano Runfola; Simona Rapposelli; Gabriella Ortore; Grazia Chiellini; Jin Hae Kim
Journal:  Int J Mol Sci       Date:  2021-03-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.